Growth inhibition of mammalian cells by eosinophil cationic protein

Takashi Maeda, Midori Kitazoe, Hiroko Tada, Rafael De Llorens, David S. Salomon, Masakazu Ueda, Hidenori Yamada, Masaharu Seno

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Eosinophil cationic protein (ECP), one of the major components of basic granules of eosinophils, is cytotoxic to tracheal epithelium. However, the extent of this effect on other cell types has not been evaluated in vitro. In this study, we evaluated the effect of ECP on 13 mammalian cell lines. ECP inhibited the growth of several cell lines including those derived from carcinoma and leukemia in dose-dependent manner. The IC50 values on A431 cells, MDA-MB-453 cells, HL-60 cells and K562 cells were estimated to be ≈1-5 μM. ECP significantly suppressed the size of colonies of A431 cells, and decreased K562 cells in G1/G0 phase. However, there was little evidence that ECP killed cells in either cell line. These effects of ECP were not enhanced by extending its N-terminus. Rhodamine B isothiocyanate-labeled ECP started to bind to A431 cells after 0.5 h and accumulated for up to 24 h, indicating that specific affinity for the cell surface may be important. The affinity of ECP for heparin was assessed and found to be reduced when tryptophan residues, one of which is located at a position in the catalytic subsite of ribonuclease in ECP, were modified. The growth-inhibitory effect was also attenuated by this modification. These results suggest that growth inhibition by ECP is dependent on cell type and is cytostatic.

Original languageEnglish
Pages (from-to)307-316
Number of pages10
JournalEuropean Journal of Biochemistry
Volume269
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Eosinophil Cationic Protein
Cells
Growth
K562 Cells
Cell Line
Cell Cycle Resting Phase
HL-60 Cells
G1 Phase
Cytostatic Agents
Ribonucleases
Eosinophils
Tryptophan
Inhibitory Concentration 50
Heparin
Leukemia
Epithelium

Keywords

  • Cell cycle
  • Colony formation
  • Cytostatic effect
  • Eosinophil cationic protein (ECP)
  • Growth inhibition

ASJC Scopus subject areas

  • Biochemistry

Cite this

Growth inhibition of mammalian cells by eosinophil cationic protein. / Maeda, Takashi; Kitazoe, Midori; Tada, Hiroko; De Llorens, Rafael; Salomon, David S.; Ueda, Masakazu; Yamada, Hidenori; Seno, Masaharu.

In: European Journal of Biochemistry, Vol. 269, No. 1, 2002, p. 307-316.

Research output: Contribution to journalArticle

Maeda, T, Kitazoe, M, Tada, H, De Llorens, R, Salomon, DS, Ueda, M, Yamada, H & Seno, M 2002, 'Growth inhibition of mammalian cells by eosinophil cationic protein', European Journal of Biochemistry, vol. 269, no. 1, pp. 307-316. https://doi.org/10.1046/j.0014-2956.2001.02653.x
Maeda, Takashi ; Kitazoe, Midori ; Tada, Hiroko ; De Llorens, Rafael ; Salomon, David S. ; Ueda, Masakazu ; Yamada, Hidenori ; Seno, Masaharu. / Growth inhibition of mammalian cells by eosinophil cationic protein. In: European Journal of Biochemistry. 2002 ; Vol. 269, No. 1. pp. 307-316.
@article{ee0d9bb4b7074102bdd02d73cdb952fa,
title = "Growth inhibition of mammalian cells by eosinophil cationic protein",
abstract = "Eosinophil cationic protein (ECP), one of the major components of basic granules of eosinophils, is cytotoxic to tracheal epithelium. However, the extent of this effect on other cell types has not been evaluated in vitro. In this study, we evaluated the effect of ECP on 13 mammalian cell lines. ECP inhibited the growth of several cell lines including those derived from carcinoma and leukemia in dose-dependent manner. The IC50 values on A431 cells, MDA-MB-453 cells, HL-60 cells and K562 cells were estimated to be ≈1-5 μM. ECP significantly suppressed the size of colonies of A431 cells, and decreased K562 cells in G1/G0 phase. However, there was little evidence that ECP killed cells in either cell line. These effects of ECP were not enhanced by extending its N-terminus. Rhodamine B isothiocyanate-labeled ECP started to bind to A431 cells after 0.5 h and accumulated for up to 24 h, indicating that specific affinity for the cell surface may be important. The affinity of ECP for heparin was assessed and found to be reduced when tryptophan residues, one of which is located at a position in the catalytic subsite of ribonuclease in ECP, were modified. The growth-inhibitory effect was also attenuated by this modification. These results suggest that growth inhibition by ECP is dependent on cell type and is cytostatic.",
keywords = "Cell cycle, Colony formation, Cytostatic effect, Eosinophil cationic protein (ECP), Growth inhibition",
author = "Takashi Maeda and Midori Kitazoe and Hiroko Tada and {De Llorens}, Rafael and Salomon, {David S.} and Masakazu Ueda and Hidenori Yamada and Masaharu Seno",
year = "2002",
doi = "10.1046/j.0014-2956.2001.02653.x",
language = "English",
volume = "269",
pages = "307--316",
journal = "FEBS Journal",
issn = "1742-464X",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Growth inhibition of mammalian cells by eosinophil cationic protein

AU - Maeda, Takashi

AU - Kitazoe, Midori

AU - Tada, Hiroko

AU - De Llorens, Rafael

AU - Salomon, David S.

AU - Ueda, Masakazu

AU - Yamada, Hidenori

AU - Seno, Masaharu

PY - 2002

Y1 - 2002

N2 - Eosinophil cationic protein (ECP), one of the major components of basic granules of eosinophils, is cytotoxic to tracheal epithelium. However, the extent of this effect on other cell types has not been evaluated in vitro. In this study, we evaluated the effect of ECP on 13 mammalian cell lines. ECP inhibited the growth of several cell lines including those derived from carcinoma and leukemia in dose-dependent manner. The IC50 values on A431 cells, MDA-MB-453 cells, HL-60 cells and K562 cells were estimated to be ≈1-5 μM. ECP significantly suppressed the size of colonies of A431 cells, and decreased K562 cells in G1/G0 phase. However, there was little evidence that ECP killed cells in either cell line. These effects of ECP were not enhanced by extending its N-terminus. Rhodamine B isothiocyanate-labeled ECP started to bind to A431 cells after 0.5 h and accumulated for up to 24 h, indicating that specific affinity for the cell surface may be important. The affinity of ECP for heparin was assessed and found to be reduced when tryptophan residues, one of which is located at a position in the catalytic subsite of ribonuclease in ECP, were modified. The growth-inhibitory effect was also attenuated by this modification. These results suggest that growth inhibition by ECP is dependent on cell type and is cytostatic.

AB - Eosinophil cationic protein (ECP), one of the major components of basic granules of eosinophils, is cytotoxic to tracheal epithelium. However, the extent of this effect on other cell types has not been evaluated in vitro. In this study, we evaluated the effect of ECP on 13 mammalian cell lines. ECP inhibited the growth of several cell lines including those derived from carcinoma and leukemia in dose-dependent manner. The IC50 values on A431 cells, MDA-MB-453 cells, HL-60 cells and K562 cells were estimated to be ≈1-5 μM. ECP significantly suppressed the size of colonies of A431 cells, and decreased K562 cells in G1/G0 phase. However, there was little evidence that ECP killed cells in either cell line. These effects of ECP were not enhanced by extending its N-terminus. Rhodamine B isothiocyanate-labeled ECP started to bind to A431 cells after 0.5 h and accumulated for up to 24 h, indicating that specific affinity for the cell surface may be important. The affinity of ECP for heparin was assessed and found to be reduced when tryptophan residues, one of which is located at a position in the catalytic subsite of ribonuclease in ECP, were modified. The growth-inhibitory effect was also attenuated by this modification. These results suggest that growth inhibition by ECP is dependent on cell type and is cytostatic.

KW - Cell cycle

KW - Colony formation

KW - Cytostatic effect

KW - Eosinophil cationic protein (ECP)

KW - Growth inhibition

UR - http://www.scopus.com/inward/record.url?scp=0036156089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036156089&partnerID=8YFLogxK

U2 - 10.1046/j.0014-2956.2001.02653.x

DO - 10.1046/j.0014-2956.2001.02653.x

M3 - Article

VL - 269

SP - 307

EP - 316

JO - FEBS Journal

JF - FEBS Journal

SN - 1742-464X

IS - 1

ER -